Klaria Pharma signs agreement with Laboratoires Plasto Sante for pharmaceutical production
Monday, July 04, 2016
Klaria Pharma Holding AB announced the signing with Laboratoires Plasto Santé sas (LPS) on the production of drugs. Production is primarily concerned with drug registration studies, but also commercial production is possible.
Klarias first drug candidate KL-00119 is scheduled to be ready for registration study in the winter of 2016/2017. For registration studies required pharmaceutical production that reflects factory conditions in large-scale commercial production. To meet this production has Klaria signed a contract with LPS is a contract manufacturer of pharmaceutical products.
"We are pleased to work with Klaria, one of the leading companies in this exciting field of drug delivery. Our strong expertise in Developing and producing transdermal patches and oral films, combined with Klaria's innovative drug delivery platform, makes this collaboration an excellent strategic fit for bothering organizations. LPS has alreadyloggedin 4 Approved Products and this new collaboration agreement will help to Accelerate Innovative Medicines Reaching the market for the benefit of patients ", says Bruno Loiseau, Managing Director of LPS.
LPS has more than 20 years of experience in the production of transdermal drugs and oral films. The company is headquartered in Paris, with research and production in Chenôve, France.
Source : klaria.com
